Top compounds associated with response to TXNL4A


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.12 0.001
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.17 0.001
mRNA phenformin GDSC1000 pan-cancer AAC 0.1 0.002
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV